Characterisation of cytosolic FK506 binding protein 12 and its role in modulating expression of Cbfa1 and osterix in ROS 17/2.8 cells

Bone

Volumn 36, Issue 2, 2005, Pages 243-253

  Varanasi, S S ^a   Datta, H K ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Core binding factor 1 (Cbfa1); FK506 Binding protein 12; Immunosuppressant FK506; Osteoblast like osteosarcoma cells (ROS 17 2.8); Osterix

Indexed keywords

CELL PROTEIN; COLECALCIFEROL; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; IMMUNOMODULATING AGENT; INSULIN; ISOPROTEIN; MESSENGER RNA; PARATHYROID HORMONE; PROTEIN OSTERIX; TACROLIMUS; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG DNA BINDING; DRUG EXPOSURE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HORMONAL REGULATION; IMMUNOLOCALIZATION; IMMUNOMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOPOROSIS; OSTEOSARCOMA CELL; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; WESTERN BLOTTING;

EID: 14144256394     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.09.021     Document Type: Article

References (32)

1. S. Epstein Posttransplantation bone disease: the role of immunosuppressive agents and the skeleton J. Bone Miner. Res. 11 1996 1 7
2. C. Movsowitz, S. Epstein, F. Ismail, M. Fallon, and S. Thomas Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption J. Bone Miner. Res. 4 1989 393 398
3. L.C. Hofbauer, C. Shui, B.L. Riggs, C.R. Dunstan, T.C. Spelsberg, and T. O'Brien Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells Biochem. Biophys. Res. Commun. 280 2001 334 339
4. J. Fukunaga, T. Yamaai, E. Yamachika, Y. Ishiwari, H. Tsujigiwa, and K. Sawaki Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506 Bone 34 2004 425 431
5. R.A. Aldape, O. Futer, M.T. DeCenzo, B.P. Jarrett, M.A. Murcko, and D.J. Livingston Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex J. Biol. Chem. 267 1992 16029 16032
6. J.A. Bennett, Y.C. Clancy, and J.D. McNeish Identification and characterization of the murine FK506 binding protein (FKBP) 12.6 gene Mamm. Genome 9 1998 1069 1071
7. C.H. Heldin, K. Miyazono, and P. ten Dijke TGF-beta signalling from cell membrane to nucleus through SMAD proteins Nature 390 1997 465 471
8. J. Massague, S.W. Blain, and R.S. Lo TGFbeta signaling in growth control, cancer, and heritable disorders Cell 103 2000 295 309
9. P. Ducy, M. Starbuck, M. Priemel, J. Shen, G. Pinero, and V. Geoffroy A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development Genet. Dev. 13 1999 1025 1036
10. K. Nakashima, X. Zhou, G. Kunkel, Z. Zhang, J.M. Deng, and R.R. Behringer The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation Cell 108 2002 17 29
11. T. Komori, H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, and K. Deguchi Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts Cell 89 1997 755 764
12. F. Otto, A.P. Thornell, T. Crompton, A. Denzel, K.C. Gilmour, and I.R. Rosewell Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development Cell 89 1997 765 771
13. D. Levanon, V. Negreanu, Y. Bernstein, I. Bar-Am, L. Avivi, and Y. Groner AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization Genomics 23 1994 425 432
14. V. Geoffroy, D.A. Corral, L. Zhou, B. Lee, and G. Karsenty Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function Mamm. Genome 9 1998 54 57
15. T. Katagiri, and N. Takahashi Regulatory mechanisms of osteoblast and osteoclast differentiation Oral Dis. 8 2002 147 159
16. H. Harada, S. Tagashira, M. Fujiwara, S. Ogawa, T. Katsumata, and A. Yamaguchi Cbfa1 isoforms exert functional differences in osteoblast differentiation J. Biol. Chem. 274 1999 6972 6978
17. S.F. Altschul, W. Gish, W. Miller, E.W. Myers, and D.J. Lipman Basic local alignment search tool J. Mol. Biol. 215 1990 403 410
18. K. Hofmann, and M. Baron Boxshade server 2003 [ http://www.ch.embnet.org/ software/BOX_form.html ]
19. D.A. Peattie, K. Hsiao, M. Benasutti, and J.A. Lippke Three distinct messenger RNAs can encode the human immunosuppressant-binding protein FKBP12 Gene 150 1994 251 257
20. Y.J. Jin, M.W. Albers, W.S. Lane, B.E. Bierer, S.L. Schreiber, and S.J. Burakoff Molecular cloning of a membrane-associated human FK506- and rapamycin-binding protein, FKBP-13 Proc. Natl. Acad. Sci. 88 1991 6677 6681
21. I.A. Katz, W.S. Jee, I.I. Joffe, B. Stein, M. Takizawa, and T.W. Jacobs Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat J. Bone Miner. Res. 7 1992 1191 1200
22. I.A. Katz, M. Takizawa, I.I. Jaffe, B. Stein, M.D. Fallon, and S. Epstein Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study Transplant 52 1991 571 574
23. M.A. Rodino, and E. Shane Osteoporosis after organ transplantation Am. J. Med. 104 1998 459 469
24. T.W. Jacobs, I.A. Katz, I.I. Joffe, B. Stein, M. Takizawa, and S. Epstein The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels Transplant. Proc. 23 1991 3188 3189
25. K.N. Weilbaecher Mechanisms of osteoporosis after hematopoietic cell transplantation Biol. Blood Marrow Transplant. 6 2000 165 174
26. G.A. Rodan, and S. Harada The missing bone Cell 89 1997 677 680
27. T. Ogawa, M. Tokuda, K. Tomizawa, H. Matsui, T. Itano, and R. Konishi Osteoblastic differentiation is enhanced by rapamycin in rat osteoblast-like osteosarcoma (ROS 17/2.8) cells Biochem. Biophys. Res. Commun. 249 1998 226 230
28. K. Tsuji, T. Komori, and M. Noda Aged mice require full transcription factor, Runx2/Cbfa1, gene dosage for cancellous bone regeneration after bone marrow ablation J. Bone Miner. Res. 9 2004 1481 1489
29. K.S. Lee, H.J. Kim, Q.L. Li, X.Z. Chi, C. Ueta, and T. Komori Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2Cl2 Mol. Cell. Biol. 20 2000 8783 8792
30. M. Sato, E. Morii, T. Komori, H. Kawahata, M. Sugimoto, and K. Terai Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues Oncogene 17 1998 1517 1525
31. S. Gutierrez, A. Javed, D.K. Tennant, M. van Rees, M. Montecino, and G.S. Stein CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergise with Runx2 at the C/EBP element to regulate bone-specific expression J. Biol. Chem. 277 2002 1316 1323
32. C.B. Cui, L.F. Cooper, X. Yang, G. Karsenty, and I. Aukhil Transcriptional coactivation of bone-specific transcription factor Cbfa1 by TAZ Mol. Cell. Biol. 23 2003 1004 1013